[DPHARMA] YoY Cumulative Quarter Result on 30-Sep-2023 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
08-Nov-2023
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2023
Quarter
30-Sep-2023 [#3]
Profit Trend
QoQ- 25.51%
YoY- -16.63%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 620,024 537,226 544,757 493,731 435,816 438,707 383,088 8.34%
PBT 62,581 56,233 69,504 65,856 55,686 56,870 42,008 6.86%
Tax -15,019 -12,090 -16,553 -15,889 -13,269 -13,630 -8,736 9.44%
NP 47,562 44,143 52,951 49,967 42,417 43,240 33,272 6.13%
-
NP to SH 47,562 44,143 52,951 49,967 42,417 43,240 33,272 6.13%
-
Tax Rate 24.00% 21.50% 23.82% 24.13% 23.83% 23.97% 20.80% -
Total Cost 572,462 493,083 491,806 443,764 393,399 395,467 349,816 8.54%
-
Net Worth 693,211 673,359 647,522 612,147 584,565 505,919 501,487 5.53%
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div 9,627 4,809 4,761 4,708 3,479 6,745 9,897 -0.45%
Div Payout % 20.24% 10.90% 8.99% 9.42% 8.20% 15.60% 29.75% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth 693,211 673,359 647,522 612,147 584,565 505,919 501,487 5.53%
NOSH 962,793 961,942 952,239 941,765 706,026 680,106 661,881 6.43%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 7.67% 8.22% 9.72% 10.12% 9.73% 9.86% 8.69% -
ROE 6.86% 6.56% 8.18% 8.16% 7.26% 8.55% 6.63% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 64.40 55.85 57.21 52.43 62.63 65.04 58.06 1.74%
EPS 4.94 4.61 5.59 5.31 6.16 6.49 5.09 -0.49%
DPS 1.00 0.50 0.50 0.50 0.50 1.00 1.50 -6.52%
NAPS 0.72 0.70 0.68 0.65 0.84 0.75 0.76 -0.89%
Adjusted Per Share Value based on latest NOSH - 961,942
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 64.41 55.81 56.59 51.29 45.27 45.57 39.79 8.35%
EPS 4.94 4.59 5.50 5.19 4.41 4.49 3.46 6.10%
DPS 1.00 0.50 0.49 0.49 0.36 0.70 1.03 -0.49%
NAPS 0.7201 0.6995 0.6726 0.6359 0.6072 0.5255 0.5209 5.54%
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 1.36 1.20 1.30 1.81 3.16 1.40 1.23 -
P/RPS 2.11 2.15 2.27 3.45 5.05 2.15 2.12 -0.07%
P/EPS 27.53 26.15 23.38 34.11 51.84 21.84 24.39 2.03%
EY 3.63 3.82 4.28 2.93 1.93 4.58 4.10 -2.00%
DY 0.74 0.42 0.38 0.28 0.16 0.71 1.22 -7.98%
P/NAPS 1.89 1.71 1.91 2.78 3.76 1.87 1.62 2.60%
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 08/11/24 08/11/23 09/11/22 18/11/21 12/11/20 29/11/19 28/11/18 -
Price 1.25 1.22 1.39 1.62 4.04 1.39 1.07 -
P/RPS 1.94 2.18 2.43 3.09 6.45 2.14 1.84 0.88%
P/EPS 25.30 26.59 25.00 30.53 66.28 21.68 21.22 2.97%
EY 3.95 3.76 4.00 3.28 1.51 4.61 4.71 -2.88%
DY 0.80 0.41 0.36 0.31 0.12 0.72 1.40 -8.89%
P/NAPS 1.74 1.74 2.04 2.49 4.81 1.85 1.41 3.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment